Dr. Khanani is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
950 Ryland St
Reno, NV 89502Phone(775) 329-0286Fax(775) 329-4243- Is this information wrong?
Education & Training
Texas Tech University Health Sciences Center at LubbockResidency, Ophthalmology, 2005 - 2008
Baylor College of MedicineInternship, Internal Medicine, 2004 - 2005- Texas Tech University Health Sciences Center at LubbockClass of 2004
Certifications & Licensure
NV State Medical License 2010 - 2023
TX State Medical License 2007 - 2012- American Board of Ophthalmology Ophthalmology
Awards, Honors, & Recognition
- Fellow (FAAO) American Academy of Ophthalmology
Clinical Trials
- Ocriplasmin Research to Better Inform Treatment (ORBIT) Start of enrollment: 2014 May 01
- A Retrospective Chart Review of Patients Treated With Ocriplasmin for Symptomatic VMA Start of enrollment: 2014 Aug 01
- Cooling Anesthesia for Intravitreal Injection Start of enrollment: 2018 Nov 30
Publications & Presentations
PubMed
- MERLIN: Phase 3a, Multicenter, Randomized, Double-Masked Trial of Brolucizumab in Participants With nAMD and Persistent Retinal Fluid.Arshad M Khanani, David M Brown, Glenn J Jaffe, Charles C Wykoff, Eser Adiguzel, Randall Wong, Xiangyi Meng, Jeffrey S Heier> ;Ophthalmology. 2022 May 7
- 6 citationsSafety Outcomes of Brolucizumab in Neovascular Age-Related Macular Degeneration: Results From the IRIS Registry and Komodo Healthcare Map.Arshad M. Khanani, Marco A. Zarbin, Mark R. Barakat, Thomas A. Albini, Peter K. Kaiser, Guruprasad B, Neetu Agashivala, Justin S Yu, Charles C. Wykoff, Mathew W MacCumber> ;JAMA Ophthalmology. 2021 Nov 24
- Novel Treatments for Diabetic Macular Edema and Proliferative Diabetic Retinopathy.Nhon Thanh Le, Zachary A. Kroeger, Weijie Violet Lin, Arshad M. Khanani, Christina Y. Weng> ;Current Diabetes Reports. 2021 Nov 1
- Join now to see all
Journal Articles
- Efficacy of Every Four Monthly and Quarterly Dosing of Faricimab vs Ranibizumab in Neovascular Age-Related Macular DegenerationArshad M Khanani, Sunil S Patel, Philip J Ferrone, Pravin U Dugel, JAMA Ophthalmology
Authored Content
- Efficacy of Every Four Monthly and Quarterly Dosing of Faricimab vs Ranibizumab in Neovascular Age-Related Macular DegenerationJuly 2020
- Efficacy of Every Four Monthly and Quarterly Dosing of Faricimab vs Ranibizumab in Neovascular Age-Related Macular DegenerationJuly 2020
- Efficacy of Every Four Monthly and Quarterly Dosing of Faricimab vs Ranibizumab in Neovascular Age-Related Macular DegenerationJuly 2020
Press Mentions
LADDER Demonstrates Efficacy of Port Delivery System with RanibizumabJuly 30th, 2019
AAO 2018: New STAIRWAY Study Data Shows Potential for Extended Durability with Faricimab in nAMDNovember 12th, 2018
A Look at 3-D Eye SurgeryJuly 26th, 2016- Join now to see all
Professional Memberships
- Fellow
Hospital Affiliations
Renown Regional Medical CenterReno, Nevada- Saint Mary's Regional Medical CenterReno, Nevada
- Northern Nevada Medical CenterSparks, Nevada
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
